Ondine Biomedical Inc. NPV (CDI) (OBI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 5.38p
   
  • Change Today:
      0.000p
  • 52 Week High: 19.00
  • 52 Week Low: 5.38
  • Currency: UK Pounds
  • Shares Issued: 226.75m
  • Volume: 0
  • Market Cap: £12.19m
  • Beta: 0.06

Company Listing Data

EPIC OBI
Sector Pharma and Biotech
ISIN CA68234M2058
Market Sector AIM
Market Segment ASQ1
Main Indices FTSE AIM All-Share
Country of register Great Britain
Currency British Pound
Market Cap £12.19m
NMS 3,000
Shares in issue 226.75m
Date Listed n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

OBI Market Data

Currency UK Pounds
Share Price 5.38p
Change Today 0.000p
% Change 0.00 %
52 Week High 19.00
52 Week Low 5.38
Volume 0
Shares Issued 226.75m
Market Cap £12.19m
Beta 0.06

OBI Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.14% below the market average44.14% below the market average44.14% below the market average44.14% below the market average44.14% below the market average
45.1% below the sector average45.1% below the sector average45.1% below the sector average45.1% below the sector average45.1% below the sector average
Price Trend
92.75% below the market average92.75% below the market average92.75% below the market average92.75% below the market average92.75% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Income Not Available
Growth
46.1% below the market average46.1% below the market average46.1% below the market average46.1% below the market average46.1% below the market average
61.11% below the sector average61.11% below the sector average61.11% below the sector average61.11% below the sector average61.11% below the sector average

OBI Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

OBI Key Personnel

Chair Jean Charest
CEO Carolyn Cross

Top of Page